Table 3.
Baseline | 3 m | 6 m | 9 m | 12 m | 15 m | 18 m | 24 m | |
---|---|---|---|---|---|---|---|---|
Informed consent sought | X | |||||||
HIV Ab/Ag test | X | X | X | X | X | X | X | X |
Syphilis serology | X | X | X | X | X | X | X | X |
CT/NG testing | X | X | X | X | X | X | X | X |
Pregnancy test * | X | X | X | X | X | X | X | X |
HBsAg & HBsAb HBV vaccine status | X | |||||||
HCV Ab | X | X | X | |||||
Serum creatinine & eGFR | X | X | X | X | X | |||
Enrolment Survey | X | |||||||
Behavioral survey | X | X | X | X | X | X | X | X |
Online in depth survey | X | X | X | X | X | |||
In depth interview | X | X | ||||||
Clinic level survey | X | X | X |
Heterosexually active females only (participants reporting risk for pregnancy only).
Ab/Ag, antibody/antigen; CT, Chlamydia trachomatis; NG, Neisseria gonorrhoeae; HBsAG, hepatitis B virus surface antigen; HBsAb, hepatitis B virus surface antibody; HCV, hepatitis C virus; eGFR, estimated glomerular filtration rate.